CVD is the main reason for a considerable increase in mortality and morbidity among people with type 2 diabetes.3 Modern pharmacologic treatment of type 2 diabetes is targeted against the different organs involved in glucose metabolism, in which a combination of different pharmacologic treatment modalities are needed when disease progression takes place
Ongoing studies continue to evaluate durability and safety outcomes
Many people notice they still enjoy certain foods, but they no longer feel controlled by urges for sweets, snacks, or fast food
Microdosing tirzepatide side effects Any GLP-1 medication can cause side effects, most commonly mild gastrointestinal ones such as nausea or digestive changes, and they tend to ease as the body adjusts
With regular use, skin appears more even toned, luminous, and well nourished
doi: 10.1186/s12866-022-02739-z 53 LiuY.TangS.FengY.XueB.ChengC.SuY.et al